Our guest on this episode is Molly White, Vice President, Medical Communications & Advocacy at Dyne Therapeutics. In our webinar last week, White discussed her perspective on the impact of the FSHD community’s role in therapy development. This is your chance to ask any questions you may have. White previously served as chief executive officer of Myotonic, an organization dedicated to advancing research and enhancing the quality of life of people living with myotonic dystrophy. In that role, she led strategic direction and administrative oversight for the comprehensive programmatic and fundraising efforts of the foundation and its staff. Molly has over 25 years of leadership-level experience building, implementing and running award-winning domestic and international community programs for organizations in both the private and nonprofit sectors.

Ver todos los episodios